TSHA Taysha Gene Therapies, Inc.

NASDAQ
$4.10

Taysha Gene Therapies, Inc. (TSHA) Earnings News

Earnings press releases, previews and reviews for Taysha Gene Therapies, Inc. (TSHA), newest first. Our most recent is review: Taysha Beats on a Narrower-Than-Expected Loss as PPQ Completion De-Risks TSHA-102, but the Investment Case Now Rests on One Binary 1H 2027 Event.